- Home
- NRC vs MAZE Comparison
NRC vs MAZE Comparison
Compare NRC & MAZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRC
- MAZE
- Stock Information
- Founded
- NRC 1981
- MAZE 2018
- Country
- NRC United States
- MAZE United States
- Employees
- NRC N/A
- MAZE N/A
- Industry
- NRC Biotechnology: Commercial Physical & Biological Resarch
- MAZE
- Sector
- NRC Health Care
- MAZE
- Exchange
- NRC Nasdaq
- MAZE NYSE
- Market Cap
- NRC 310.8M
- MAZE 367.0M
- IPO Year
- NRC N/A
- MAZE 2025
- Fundamental
- Price
- NRC $15.10
- MAZE $15.73
- Analyst Decision
- NRC
- MAZE Strong Buy
- Analyst Count
- NRC 0
- MAZE 4
- Target Price
- NRC N/A
- MAZE $23.50
- AVG Volume (30 Days)
- NRC 102.0K
- MAZE 124.6K
- Earning Date
- NRC 08-05-2025
- MAZE 08-14-2025
- Dividend Yield
- NRC 3.14%
- MAZE N/A
- EPS Growth
- NRC N/A
- MAZE N/A
- EPS
- NRC 1.02
- MAZE 0.34
- Revenue
- NRC $141,298,000.00
- MAZE $167,500,000.00
- Revenue This Year
- NRC N/A
- MAZE N/A
- Revenue Next Year
- NRC N/A
- MAZE N/A
- P/E Ratio
- NRC $15.08
- MAZE $47.25
- Revenue Growth
- NRC N/A
- MAZE N/A
- 52 Week Low
- NRC $9.76
- MAZE $6.71
- 52 Week High
- NRC $27.07
- MAZE $17.00
- Technical
- Relative Strength Index (RSI)
- NRC 40.98
- MAZE N/A
- Support Level
- NRC $16.28
- MAZE N/A
- Resistance Level
- NRC $16.36
- MAZE N/A
- Average True Range (ATR)
- NRC 0.72
- MAZE 0.00
- MACD
- NRC -0.29
- MAZE 0.00
- Stochastic Oscillator
- NRC 8.75
- MAZE 0.00
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
About MAZE MAZE THERAPEUTICS INC
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.